Graham, C., Kao, R., Cao, Q., Grover, P., Norton, J., McDonald-Hyman, C., Maakaron, J., Allred, J., Bachanova, V., Miller, J., Weisdorf, D., Juckett, M. (2025). Allogeneic hematopoietic stem cell transplantation for hematological malignancies using nonmyeloablative fludarabine, cyclophosphamide, 200 centigray total body irradiation, and post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil for graft-versus-host disease prophylaxis is associated with low non-relapse mortality.. Blood. https://doi.org/10.1182/blood-2025-4220